Recombinant NMM fusion antigen plasmid DNA vaccine(Gu 'an Dingtai Haigui Biotech)

重组NMM融合抗原质粒DNA疫苗(固安鼎泰海规生物)

Report date: 2023/01/29 15:03:19

Base Information

Drug NameRecombinant NMM fusion antigen plasmid DNA vaccine(Gu 'an Dingtai Haigui Biotech)
Drug Alias NameNMM肿瘤治疗性DNA疫苗裸质粒注射液抗肿瘤重组NMM融合抗原质粒DNA疫苗
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGu 'an Dingtai Haigui Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGu 'an Dingtai Haigui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A